Cafepharma Today

May 30 2025 - #ASCO25 tracker: Meeting kicks off in Chicago with high expectations in breast, lung cancer
#ASCO25 tracker: Meeting kicks off in Chicago with high expectations in breast, lung cancer
Roche links BTK inhibitor to low relapse rate across 96-week multiple sclerosis trial
Mixed COPD results for Regeneron, Sanofi drug cloud approval chances
Illumina introduces a new AI algorithm PromoterAI
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Cubicin Drives Cubist Pharma
Yahoo/Zacks
Saturday, January 21, 2012 - 12:02pm
tags:
Cubicin, Cubist Pharmaceuticals, antibiotics
Is Biogen's Stock Reasonable by the Numbers?
Motley Fool
Saturday, January 21, 2012 - 12:00pm
tags:
Biogen
Sequenom expects to raise $54M from stock sale
Yahoo/AP
Friday, January 20, 2012 - 12:24pm
tags:
stock offering, Sequenom
Novartis falls 4% on MS drug concerns
Marketwatch
Friday, January 20, 2012 - 12:19pm
tags:
MS, Novartis, Gilenya, multiple sclerosis
Drug lobby wants clearer FDA rules for diet pills
Reuters
Friday, January 20, 2012 - 11:32am
tags:
FDA, diet pills, PhRMA, PDUFA, Sanofi
Biotechnology Funding Hits 4-Year High
Bloomberg
Friday, January 20, 2012 - 11:29am
tags:
funding, biotech
Forbes Earnings Preview: Abbott Laboratories
Forbes
Friday, January 20, 2012 - 11:23am
tags:
earnings, Abbott Laboratories
Novartis’s Gilenya Reviewed After 11 Deaths
Bloomberg
Friday, January 20, 2012 - 10:06am
tags:
Novartis, Gilenya, MS, multiple sclerosis, EMA
No Vacancy: Workers Need Not Apply to This Sector
Motley Fool
Friday, January 20, 2012 - 10:02am
tags:
layoffs, pharma industry
Cubist Pharma 4Q profit falls 53 percent
Yahoo/AP
Friday, January 20, 2012 - 9:59am
tags:
earnings, Cubist Pharmaceuticals
Dividends, Drug Stocks And Owner Earnings
Seeking Alpha
Friday, January 20, 2012 - 9:59am
tags:
dividends, drug stocks, Merck, Eli Lilly, Pfizer, Bristol-Myers Squibb
Genzyme, Veracyte announce global co-promotion agreement
The Fly on the Wall
Friday, January 20, 2012 - 9:57am
tags:
Genzyme, Veracyte, Afirma Thyroid FNA Analysis
Why Prolor Biotech Is Rising And Other Attractive Prospects
Seeking Alpha
Friday, January 20, 2012 - 9:55am
tags:
Prolor, Abbott Laboratories, Alnylam, GSK, Merck, Pfizer, Lilly, Roche
Merck to settle Canada Vioxx suits for up to C$37M
Yahoo/AP
Friday, January 20, 2012 - 9:54am
tags:
Merck, Canada, Vioxx, settlements
Alnylam Pharma To Cut 33% Of Jobs
NASDAQ.com
Thursday, January 19, 2012 - 6:47pm
tags:
Alnylam, layoffs
Gardasil vs. Cervarix: How are MDs vaccinating against HPV?
Fierce Pharma/Sermo
Thursday, January 19, 2012 - 12:07pm
tags:
HPV, Merck, Gardasil, Cervarix, vaccines, GSK
AZ chief: Emerging markets are tougher than you think
Fierce Pharma
Thursday, January 19, 2012 - 12:05pm
tags:
AstraZeneca, emerging markets, David Brennan, Pharma CEOs
J&J to pay $158 million to settle Risperdal case
Markewatch
Thursday, January 19, 2012 - 12:03pm
tags:
settlements, JNJ, Risperdal
Gilead's Viread new formulations approved by FDA for use by children with HIV
Yahoo/Fly on the Wall
Thursday, January 19, 2012 - 11:13am
tags:
Viread, Gilread, HIV, FDA
Biopharma Stocks To Watch This Week
Seeking Alpha
Thursday, January 19, 2012 - 11:12am
tags:
BioDelivery Sciences, Biovest International, Celldex, MannKind, NovaBay Pharmaceuticals, Keryx, ImmunoCellular, Cel-Sci, Dendreon, Generex, Human Genome Sciences

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.